Modelling the long-term cost-effectiveness of Riluzole for the treatment of Amytrophic Lateral Sclerosis (ALS)

Manouchehr Tavakoli, Huw Talfryn Oakley Davies, M Malek

Research output: Other contribution

Original languageEnglish
Volume2
Publication statusPublished - 1999

Cite this